GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Current Ratio

Gemina Laboratories (XCNQ:GLAB) Current Ratio : 0.13 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Gemina Laboratories's current ratio for the quarter that ended in Oct. 2023 was 0.13.

Gemina Laboratories has a current ratio of 0.13. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Gemina Laboratories has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Gemina Laboratories's Current Ratio or its related term are showing as below:

XCNQ:GLAB' s Current Ratio Range Over the Past 10 Years
Min: 0.13   Med: 1.87   Max: 4.41
Current: 0.13

During the past 3 years, Gemina Laboratories's highest Current Ratio was 4.41. The lowest was 0.13. And the median was 1.87.

XCNQ:GLAB's Current Ratio is ranked worse than
95.54% of 1547 companies
in the Biotechnology industry
Industry Median: 3.8 vs XCNQ:GLAB: 0.13

Gemina Laboratories Current Ratio Historical Data

The historical data trend for Gemina Laboratories's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Current Ratio Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23
Current Ratio
1.05 2.93 0.32

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.43 0.32 1.29 0.28 0.13

Competitive Comparison of Gemina Laboratories's Current Ratio

For the Biotechnology subindustry, Gemina Laboratories's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Current Ratio distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Current Ratio falls into.



Gemina Laboratories Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Gemina Laboratories's Current Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Current Ratio (A: Jan. 2023 )=Total Current Assets (A: Jan. 2023 )/Total Current Liabilities (A: Jan. 2023 )
=0.563/1.748
=0.32

Gemina Laboratories's Current Ratio for the quarter that ended in Oct. 2023 is calculated as

Current Ratio (Q: Oct. 2023 )=Total Current Assets (Q: Oct. 2023 )/Total Current Liabilities (Q: Oct. 2023 )
=0.276/2.126
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gemina Laboratories  (XCNQ:GLAB) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Gemina Laboratories Current Ratio Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories (XCNQ:GLAB) Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines